CCO Expert Recap

HBV Expert Recap of AASLD 2008

Source: CCO Official Conference Coverage of the 2008 AASLD Meeting*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

HBV Expert Recap of AASLD 2008

Faculty:

Nezam H. Afdhal, MD, FRCPI
Ira M. Jacobson, MD
Jules L. Dienstag, MD

Fred Poordad, MD

CREDIT INFORMATION

Release Date: 01/08/09

Expiration Date: 01/07/10

Physicians: maximum of 0.75 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Recount recent data on novel therapies for the treatment of chronic hepatitis B
Discuss new findings on the efficacy of US Food and Drug Administration–approved agents for the treatment of patients with chronic hepatitis B
Describe new data on management strategies for treatment-naive hepatitis B patients
Recount recent insights into the management of patients with drug-resistant hepatitis B virus infection or suboptimal response

CCO Expert Recaps combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.